Central Pharmaceutical Joint Stock Company No3 reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was VND 97,995.19 million compared to VND 125,512.6 million a year ago. Net income was VND 50,537.34 million compared to VND 40,745.86 million a year ago.

Basic earnings per share from continuing operations was VND 2,233 compared to VND 1,800.4 a year ago.